Cargando…

Oral vinorelbine in metastatic breast cancer

Detalles Bibliográficos
Autores principales:	Conte, PF, Giovannelli, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231909/ http://dx.doi.org/10.1186/bcr1229

Ejemplares similares

Future role of bevacizumab in breast cancer
por: Conte, PF, et al.
Publicado: (2009)

Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
por: Huang, Liang, et al.
Publicado: (2019)

Targeting the right chemotherapy for the right patient
por: Conte, PF, et al.
Publicado: (2005)

Activation of TGF-beta signalling in breast cancer metastatic cells
por: Giampieri, S, et al.
Publicado: (2008)

Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis
por: Valerio, Maria Rosaria, et al.
Publicado: (2021)

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial
por: Tubiana-Mathieu, N, et al.
Publicado: (2009)

Can high-frequency ultrasound predict metastatic lymph nodes in patients with invasive breast cancer?
por: Clough, GR, et al.
Publicado: (2004)

Pathological features and patterns of metastatic disease in locally advanced inflammatory and non-inflammatory breast cancer
por: Mvere, MZ, et al.
Publicado: (2009)

Ablation for metastatic lung cancer
por: de Baère, Thierry
Publicado: (2015)

Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer
por: Colomer, R, et al.
Publicado: (2005)

Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial
por: Li, Dou-Dou, et al.
Publicado: (2022)

Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series
por: Stravodimou, Athina, et al.
Publicado: (2014)

The neurobiology of oral cancer pain
por: Schmidt, Brian L
Publicado: (2014)

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer
por: Baselga, J, et al.
Publicado: (2011)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Brain lesions in oncology patients: recognising metastatic versus non metastatic lesions
por: Rich, Philip
Publicado: (2015)

Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy
por: Andres, R, et al.
Publicado: (2002)

Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial
por: Wu, Shuo, et al.
Publicado: (2020)

Vinorelbine induced perforation of a metastatic gastric lesion
por: Mullally, W. J., et al.
Publicado: (2016)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Genomic profiling of breast cancer
por: Borg, Å
Publicado: (2005)

Update on breast cancer genetics
por: Izatt, L
Publicado: (2006)

Clinical breast cancer and estrogen
por: Chew, HK
Publicado: (2003)

Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000)

Immunity and autoimmunity in breast cancer
por: Curigliano, G
Publicado: (2011)

An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer
por: Pujol, Jean-Louis, et al.
Publicado: (2019)

Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)
por: Sim, Sung Hoon, et al.
Publicado: (2019)

Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure
por: Bonneterre, J, et al.
Publicado: (2002)

Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer
por: Ferrario, Cristiano, et al.
Publicado: (2016)

Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2021)

Revealing cancer initiating cells in metastatic melanomas by harnessing the host′s anti tumor humoral immune mechanisms
por: Kotlan, Beatrix, et al.
Publicado: (2014)

Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?
por: Sankaye, P, et al.
Publicado: (2012)

The role of Xeloda in metastasic breast cancer
por: Cortés-Funes, H
Publicado: (2005)

ATM mutations associated with breast cancer
por: Gatti, RA, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ct3cn2am31rp11ppmuovo55dmi